Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

NANTUCKET COTTAGE HOSPITAL

NPI: 1447214622 · NANTUCKET, MA 02554 · Critical Access Hospital · NPI assigned 04/14/2006

$7.11M
Total Medicaid Paid
183,556
Total Claims
153,192
Beneficiaries
175
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialFISHMAN, AARON (VP FINANCE)
NPI Enumeration Date04/14/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 18,575 $733K
2019 19,741 $842K
2020 18,994 $659K
2021 41,711 $1.45M
2022 40,364 $1.73M
2023 28,460 $821K
2024 15,711 $874K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 10,913 9,699 $1.52M
99283 Emergency department visit for the evaluation and management, moderate severity 7,622 6,915 $848K
96361 Intravenous infusion, hydration; each additional hour 1,383 1,219 $700K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 2,496 2,293 $511K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 8,905 3,282 $463K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 2,959 1,016 $360K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 3,136 2,833 $356K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4,569 3,787 $330K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 821 674 $214K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4,335 4,139 $147K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 4,585 1,886 $101K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,214 1,112 $94K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,227 1,072 $88K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,642 1,477 $85K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,346 1,853 $69K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2,882 2,319 $54K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,801 1,600 $53K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 616 435 $49K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 10,100 8,358 $48K
96375 Therapeutic injection; each additional sequential IV push 1,497 1,237 $44K
71046 Radiologic examination, chest; 2 views 1,871 1,782 $43K
0002A 1,261 936 $40K
77063 Screening digital breast tomosynthesis, bilateral 566 557 $39K
0001A 1,300 947 $38K
74177 Computed tomography, abdomen and pelvis; with contrast material 289 285 $38K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,518 1,472 $35K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,518 1,472 $35K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 118 104 $32K
97161 429 419 $28K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 699 365 $27K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,602 1,572 $26K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3,820 3,413 $23K
80053 Comprehensive metabolic panel 6,656 5,809 $23K
ATP14 2,658 2,265 $21K
84443 Thyroid stimulating hormone (TSH) 2,380 2,295 $20K
76801 124 113 $20K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 568 525 $19K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 118 110 $18K
ATP15 1,945 1,592 $18K
ATP08 2,451 2,118 $17K
70450 Computed tomography, head or brain; without contrast material 99 96 $16K
87086 Culture, bacterial; quantitative colony count, urine 2,674 2,429 $16K
97530 Therapeutic activities, direct patient contact, each 15 minutes 320 202 $14K
84484 1,472 1,268 $14K
90686 1,834 1,805 $13K
97803 172 141 $13K
85027 3,348 2,854 $13K
81001 5,684 4,834 $12K
80048 Basic metabolic panel (calcium, ionized) 6,448 5,479 $11K
77067 Screening mammography, bilateral, including computer-aided detection 570 561 $10K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,111 1,050 $10K
83036 Hemoglobin; glycosylated (A1C) 2,435 2,379 $10K
97162 129 127 $9K
87070 1,555 1,482 $9K
81025 1,836 1,730 $9K
87806 499 486 $9K
86803 997 980 $8K
83735 2,071 1,726 $8K
ATP17 943 853 $8K
86618 715 699 $8K
80050 General health panel 607 605 $8K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 332 278 $7K
G0378 Hospital observation service, per hour 48 44 $7K
83655 701 684 $7K
0004A 177 171 $7K
83690 1,382 1,253 $6K
90460 Immunization administration through 18 years of age via any route, first or only component 348 345 $6K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 106 106 $6K
71045 Radiologic examination, chest; single view 525 474 $6K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 39 39 $6K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 64 64 $6K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 372 369 $6K
0012A 167 139 $5K
87276 490 475 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 103 69 $4K
0011A 178 147 $4K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 85 78 $4K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 146 144 $4K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 674 607 $4K
81003 2,016 1,595 $4K
85610 1,623 987 $3K
J3490 Unclassified drugs 483 405 $3K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 83 76 $3K
87077 522 496 $3K
ATP03 594 538 $3K
76830 Ultrasound, transvaginal 38 38 $3K
97802 38 38 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 2,726 2,640 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete 14 14 $3K
80306 247 214 $3K
82728 327 317 $2K
83605 276 249 $2K
86850 288 267 $2K
0124A 44 44 $2K
0071A 52 42 $2K
84702 164 114 $2K
74176 Computed tomography, abdomen and pelvis; without contrast material 12 12 $2K
80061 Lipid panel 3,969 3,878 $2K
J2704 Injection, propofol, 10 mg 734 697 $2K
0064A 45 44 $2K
84439 271 262 $2K
0072A 35 35 $2K
87186 253 243 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 77 76 $1K
83550 292 283 $1K
85651 525 497 $1K
84153 102 101 $1K
87210 290 278 $1K
J7050 Infusion, normal saline solution, 250 cc 691 434 $1K
90670 25 25 $1K
86140 276 256 $989.31
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,007 872 $938.30
82570 339 312 $899.81
87340 110 109 $891.56
83540 284 275 $863.90
86900 346 320 $861.38
73564 56 52 $849.39
G0463 Hospital outpatient clinic visit for assessment and management of a patient 34 26 $830.18
86901 330 305 $810.86
J1885 Injection, ketorolac tromethamine, per 15 mg 1,298 1,170 $726.42
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 14 14 $705.74
73630 27 24 $694.05
85018 350 296 $683.15
0054A 24 15 $642.18
87040 47 45 $623.34
90472 Immunization administration, each additional vaccine (list separately) 757 724 $546.48
82607 64 64 $502.45
85014 253 244 $488.59
86756 40 40 $470.40
73130 16 13 $408.34
ATP16 39 37 $405.18
86617 43 42 $384.03
87205 132 122 $343.07
73030 14 13 $317.28
73610 14 12 $306.26
90682 18 18 $280.18
J7030 Infusion, normal saline solution , 1000 cc 374 304 $242.28
84403 13 12 $227.60
86592 71 71 $225.19
85379 27 24 $202.60
86780 15 15 $181.05
J2250 Injection, midazolam hydrochloride, per 1 mg 39 39 $178.17
86762 13 13 $170.69
86787 13 13 $152.75
80076 2,685 2,395 $145.88
J1100 Injection, dexamethasone sodium phosphate, 1 mg 142 137 $124.72
J7120 Ringers lactate infusion, up to 1000 cc 43 40 $121.14
83615 319 283 $105.30
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 308 292 $101.11
87081 12 12 $70.20
87184 12 12 $62.90
82043 12 12 $42.24
82947 14 14 $38.17
85007 15 13 $28.17
84100 157 126 $21.46
84550 13 12 $4.12
36415 Collection of venous blood by venipuncture 2,377 1,888 $3.23
J2060 Injection, lorazepam, 2 mg 18 12 $0.92
91300 2,586 1,713 $0.02
36416 554 477 $0.00
82962 440 368 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 659 627 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 41 37 $0.00
91301 280 214 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 15 13 $0.00
87468 28 27 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 18 13 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 710 669 $0.00
91312 44 44 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 187 159 $0.00
90633 31 26 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 15 14 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 45 37 $0.00
87469 14 14 $0.00
90734 13 13 $0.00